NeuroPace
NasdaqGM:NPCE
$ 13,27
$-0,10 (-0,75%)
13,27 $
$-0,10 (-0,75%)
End-of-day quote: 03/24/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

G
15,34%
3-year Growth Rate
R
0/0
3-year Risk Analysis
O
-1,00%
Outlook 12/26
W
-172%
Margin of safety
T
50,72%
Analyst Price Target
H
DOWN
50-week EMA Trend

Company Info

EPS Growth 5Y
62,15%
Revenue growth 5Y
6,32%
Price growth 5Y
-47,84%
Market Cap
$0,45 B
Long-Term Debt
$0,06 B
Short Interest
0,00%
Quarterly earnings
05/08/2026 (E)
Dividend
$0,00
Dividend Yield
0,00%
Industry
ISIN Number

NeuroPace Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

$20,00
50.72%
50.72
Last Update: 03/23/2026
Analysts: 8

Highest Price Target $22,00

Average Price Target $20,00

Lowest Price Target $18,00

Top growth stocks in the health care sector

Stock Rate of Return 5Y Price 5Y Div. 5Y G R O W T H
NeuroPace
NasdaqGM:NPCE
-47,84% -47,84% 0,00% 15,34% 0/0 -1,00% -172,24% 50,72% DOWN
×